CALCIJECT INJ 100MG/ML 100 MG
CALCIUM CHLORIDE : 100 MG · DIN 00821780 · OMEGA LABORATORIES LIMITED
Health Canada status: MARKETED
What is CALCIJECT INJ 100MG/ML?
CALCIJECT INJ 100MG/ML 100 MG contains CALCIUM CHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00821780, held by OMEGA LABORATORIES LIMITED, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 25-Jun-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00821780 |
|---|---|
| Brand name | CALCIJECT INJ 100MG/ML |
| Generic / active ingredient | CALCIUM CHLORIDE : 100 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 100 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA07 CALCIUM CHLORIDE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Jun-2026 |
| Original market date | 1990-12-31 00:00:00 |
Is CALCIUM CHLORIDE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B05XA07 CALCIUM CHLORIDE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CALCIUM CHLORIDE INJECTION USP | 100 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00294748 |
| CALCIUM CHLORIDE INJECTION BP | 100 MG | SOLUTION | STERIMAX INC | DORMANT | DIN 02495945 |
| CALCIUM-35 0.25 - 10 | 12.9 G | POWDER FOR SOLUTION | ALTHIN BIOPHARM INC. | CANCELLED POST MARKET | DIN 00798916 |
| CALCIUM-36.8 0.5-4.5 | 12.2 G | POWDER | ALTHIN BIOPHARM INC. | CANCELLED POST MARKET | DIN 02160994 |
Who else supplies CALCIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CALCIUM CHLORIDE appears in 1674 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.